BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 16411052)

  • 21. A 25-year follow-up of a population screened with faecal occult blood test in Finland.
    Malila N; Hakama M; Pukkala E
    Acta Oncol; 2007; 46(8):1103-6. PubMed ID: 17851857
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The role of primary care in colorectal cancer screening: experience from Czech Republic.
    Seifert B; Zavoral M; Fric P; Bencko V
    Neoplasma; 2008; 55(1):74-80. PubMed ID: 18190246
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Obstacles to colorectal screening in general practice: a qualitative study of GPs and patients.
    Aubin-Auger I; Mercier A; Lebeau JP; Baumann L; Peremans L; Van Royen P
    Fam Pract; 2011 Dec; 28(6):670-6. PubMed ID: 21551256
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [General practitioners' experience in a mass screening campaign of colorectal cancers].
    Durand G; Arveux P; Milan C; Quelier C; Bedenne L; Faivre J
    Cah Sociol Demogr Med; 1992; 32(2-3):191-205. PubMed ID: 1297544
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Screening for common mental disorders: who will benefit? Results from a randomised clinical trial.
    Christensen KS; Toft T; Frostholm L; Ornbøl E; Fink P; Olesen F
    Fam Pract; 2005 Aug; 22(4):428-34. PubMed ID: 15897212
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Colorectal cancer screening among the medically underserved.
    Wolf MS; Satterlee M; Calhoun EA; Skripkauskas S; Fulwiler D; Diamond-Shapiro L; Alvarez H; Eder M; Mukundan P
    J Health Care Poor Underserved; 2006 Feb; 17(1):47-54. PubMed ID: 16520508
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Colonoscopy results of a French regional FOBT-based colorectal cancer screening program with high compliance.
    Manfredi S; Piette C; Durand G; Plihon G; Mallard G; Bretagne JF
    Endoscopy; 2008 May; 40(5):422-7. PubMed ID: 18231963
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Predictors of colorectal cancer screening from patients enrolled in a managed care health plan.
    Farmer MM; Bastani R; Kwan L; Belman M; Ganz PA
    Cancer; 2008 Mar; 112(6):1230-8. PubMed ID: 18266204
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Colorectal cancer screening: how to help patients comply.
    Goldsmith G; Chiaro C
    J Fam Pract; 2008 Jul; 57(7):E2-7. PubMed ID: 18625166
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cost evaluation in a colorectal cancer screening programme by faecal occult blood test in the District of Florence.
    Grazzini G; Ciatto S; Cislaghi C; Castiglione G; Falcone M; Mantellini P; Zappa M;
    J Med Screen; 2008; 15(4):175-81. PubMed ID: 19106257
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Colorectal cancer screening among first-degree relatives of colorectal cancer patients: benefits and barriers.
    Mack LA; Cook LS; Temple WJ; Carlson LE; Hilsden RJ; Paolucci EO
    Ann Surg Oncol; 2009 Aug; 16(8):2092-100. PubMed ID: 19479307
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Measuring the quality of colorectal cancer screening: the importance of follow-up.
    Etzioni DA; Yano EM; Rubenstein LV; Lee ML; Ko CY; Brook RH; Parkerton PH; Asch SM
    Dis Colon Rectum; 2006 Jul; 49(7):1002-10. PubMed ID: 16673056
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nonmedical costs of colorectal cancer screening with the fecal occult blood test and colonoscopy.
    Heitman SJ; Au F; Manns BJ; McGregor SE; Hilsden RJ
    Clin Gastroenterol Hepatol; 2008 Aug; 6(8):912-917.e1. PubMed ID: 18534918
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The effects of promoting colorectal cancer screening on screening utilisation: evaluation of the German Campaign "Aktiv gegen Darmkrebs" (Action against Colorectal Cancer).
    Loss J; Eichhorn C; Nagel E
    Z Gastroenterol; 2006 Nov; 44(11):1127-34. PubMed ID: 17115353
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Colorectal cancer screening using fecal occult blood test and subsequent risk of colorectal cancer: a prospective cohort study in Japan.
    Lee KJ; Inoue M; Otani T; Iwasaki M; Sasazuki S; Tsugane S;
    Cancer Detect Prev; 2007; 31(1):3-11. PubMed ID: 17289293
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Feasibility of colorectal cancer screening with fecal occult blood test distributed by public pharmacies].
    Pippa G; Ferrara M; Valle S; Diego B; Alessandra B; Apuzzo M; Bazuro ME; Tammaro G; Federici A
    Recenti Prog Med; 2009; 100(7-8):348-51. PubMed ID: 19725474
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cost-effectiveness analysis on screening for colorectal neoplasm and management of colorectal cancer in Asia.
    Tsoi KK; Ng SS; Leung MC; Sung JJ
    Aliment Pharmacol Ther; 2008 Aug; 28(3):353-63. PubMed ID: 18638075
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Overcoming barriers to colorectal cancer screening tests.
    Lachter J; Leska-Aharoni T; Warum D; Eliakim R
    Isr Med Assoc J; 2008; 10(8-9):621-6. PubMed ID: 18847166
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bowel cancer screening in England: a qualitative study of GPs' attitudes and information needs.
    Woodrow C; Rozmovits L; Hewitson P; Rose P; Austoker J; Watson E
    BMC Fam Pract; 2006 Sep; 7():53. PubMed ID: 16981989
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Provision of smoking cessation counseling by general practitioners assisted by training and screening procedure.
    Ulbricht S; Meyer C; Schumann A; Rumpf HJ; Hapke U; John U
    Patient Educ Couns; 2006 Oct; 63(1-2):232-8. PubMed ID: 16531000
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.